VHL and nonpapillary renal cell carcinoma: Clinically, low SETD2 is highly related to reduced VHL in mRNA and protein levels (TCGA-KIRC database, Supplementary Fig. 4f, g), suggesting an association between SETD2 loss and decreased VHL expression in the context of ccRCC.